Funds & ETFs 

The problem with the People's Trust and buying biotech

Daniel Godfrey’s People’s Trust collapsed this week after initial enthusiasm for his sustainable fund idea failed to translate into cold, hard cash. The former Investment Association chief was forced to cancel his trust’s IPO after institutional investors and wealth managers stayed away – here’s why.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now